Connective tissue diseases: systemic sclerosis: beyond limited and diffuse subsets? 2014

John Varga, and Monique Hinchcliff
Feinberg School of Medicine, Division of Rheumatology and Northwestern Scleroderma Program Northwestern University, 240 East Huron Street, Chicago, IL 60657, USA.

Patients with systemic sclerosis present with varying clinical features, have different responses to therapy, and end up with different outcomes. Categorizing patients improves disease management. A new study now proposes that patients with systemic sclerosis and overlapping features of another connective tissue disease might form a distinct disease subset.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003240 Connective Tissue Diseases A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides. Connective Tissue Disease,Disease, Connective Tissue,Diseases, Connective Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

John Varga, and Monique Hinchcliff
January 2023, Heart failure clinics,
John Varga, and Monique Hinchcliff
March 2016, Nature reviews. Rheumatology,
John Varga, and Monique Hinchcliff
December 2011, Nature reviews. Rheumatology,
John Varga, and Monique Hinchcliff
June 2014, Nature reviews. Rheumatology,
John Varga, and Monique Hinchcliff
August 1975, Nursing mirror and midwives journal,
John Varga, and Monique Hinchcliff
January 2011, Nature reviews. Rheumatology,
John Varga, and Monique Hinchcliff
August 2014, Nature reviews. Rheumatology,
John Varga, and Monique Hinchcliff
March 2024, Seminars in respiratory and critical care medicine,
John Varga, and Monique Hinchcliff
May 1982, The British journal of dermatology,
John Varga, and Monique Hinchcliff
February 1985, Klinicheskaia meditsina,
Copied contents to your clipboard!